Table 7.
Types of hybrid nanoparticles and their applications in cancer therapy.
| Entity | Type of NP | Type of Cancer | References |
|---|---|---|---|
| Gold nanoparticles (GNPOPs)-single wall carbon nanotubes (SWCNts) | Breast cancer | [123] | |
| RBC-B16 hybrid membrane camouflaged doxorubicin (DOX)-loaded hollow copper sulphide nanoparticles | DCuS@[RBC-B16] NPs | Melanoma | [124] |
| Dendrimer-entrapped gold nanoparticles | Au DENPs-FA | Lung cancer | [125] |
| Polymer lipid hybrid nanoparticles (PLNs) plus doxorubicin (Dox) | Dox-PLNs | Breast cancer | [126] |
| Hybrid elastin like polypeptide/liposome nanoparticles | Prostate cancer | [127] | |
| Core-shell lipid-polymer hybrid nanoparticles | CSLPHNPs | Prostate cancer | [128] |
| Sialic acid-modified chitosan-PLGA hybrid nanoparticles | SC-PLGA NPs | Lymphoma | [129] |
| Genistein-PEGylated silica hybrid nanomaterials | Gen-PEG-SiHNMs | Colon cancer | [130] |